葵花药业 (002737)
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 58400.00
- Circulating A-Shares(W): 58400.00
- Earnings Per Share(RMB): -0.0600
- Net Assets Per Share(RMB): 6.9394
- Operating Revenue(W RMB): 168398.40
- Total Profit(W RMB): -623.48
- Net Profit Attributable to Parent(W RMB): -3353.87
- Net Profit Growth Rate(%): -105.72
- Weighted Return on Equity(%): -0.7700
- Operating Cash Flow Per Share(RMB): 0.3770
- Undistributed Profit Per Share(RMB): 3.8393
- Capital Reserve Per Share(RMB): 1.5727
2. Main Business
The main business covers:
- Research, manufacturing and marketing of pharmaceuticals
- Research, manufacturing and marketing of health and wellness products
3. Company Basic Information
- Company Name: Sunflower Pharmaceutical Group Co., Ltd.
- Listing Date: 2014-12-30
- Industry: Pharmaceutical Manufacturing
- Address: No. 18 Donghu Road, Yingbin Road Concentration Zone, Harbin High-tech Industrial Development Zone, Heilongjiang Province, China
- Website: www.kuihuayaoye.com
- Company Profile: The Company was established by the overall change of Sunflower Pharmaceutical Group Co., Ltd. into a joint stock company. On August 2, 2009, Sunflower Limited held a shareholders' meeting, and with the unanimous consent of all shareholders, Sunflower Limited used the net assets of RMB 95,297,582.57 as of December 31, 2008, audited by Zhongrui Yuehua's "Audit Report" (Zhongrui Yuehua Audit No. [2009] 05349), distributed a cash dividend of RMB 7,647,824.33, and then converted into 86.8 million shares at a ratio of 1:0.99, with the remaining RMB 849,758.24 included in capital reserve. On August 17, 2009, Zhongrui Yuehua issued the "Capital Verification Report" (Zhongrui Yuehua Verification No. (2009) 109), verifying the capital contribution for this overall change to establish a joint stock company. On September 1, 2009, the Company obtained the "Business License" (Registration No. 230199100055264).
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Sunflower Group Co., Ltd. | General Legal Person | 26520.00 | 45.41 |
| 2 | Heilongjiang Jinkui Investment Co., Ltd. | General Legal Person | 2400.00 | 4.11 |
| 3 | E Fund CSI Dividend ETF | Fund | 340.08 | 0.58 |
| 4 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 284.12 | 0.49 |
| 5 | China Merchants CSI Dividend ETF | Fund | 283.82 | 0.49 |
| 6 | Southern CSI 1000 ETF | Fund | 267.57 | 0.46 |
| 7 | Xiangcai Pharmaceutical Health Hybrid Securities Investment Fund Class A | Fund | 16.87 | 0.03 |
| 8 | Hui'an Asset Rotation Flexible Allocation Hybrid Securities Investment Fund Class A | Fund | 3.35 | 0.01 |
5. Concept Sectors
- Infant & Child Concept
- Vitamin
- Hepatitis Concept
- Innovative Drugs
- Margin Trading & Securities Lending
- High Dividend Stocks
- SME 300 Index
- CSI Dividend Index
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information